Payment overview · 2025
General Payments
$65.62
3 reported records · 2 companies
Healthcare provider profile · identity verified
Garrett Howard Smith, M.D.
Allopathic & Osteopathic Physicians|Radiology|Neuroradiology · NOVI, MI · NPI 1053519298
Verified facts
What the public records show
CMS Open Payments records show Garrett Howard Smith, M.D. received $65.62 in general payments during 2025 across 3 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 68.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $45.21 | 68.9% | 2 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $20.41 | 31.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $65.62 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $45.21 | 2 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $20.41 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1075 | 317 |
| Eliquis | Apixaban | 953 | 158 |
| Levothyroxine Sodium | Levothyroxine Sodium | 668 | 203 |
| Furosemide | Furosemide | 561 | 161 |
| Amlodipine Besylate | Amlodipine Besylate | 545 | 156 |
| Potassium Chloride | Potassium Chloride | 426 | 129 |
| Metoprolol Succinate | Metoprolol Succinate | 396 | 134 |
| Lisinopril | Lisinopril | 372 | 101 |
| Trazodone Hcl | Trazodone Hcl | 368 | 87 |
| Tamsulosin Hcl | Tamsulosin Hcl | 344 | 103 |
| Sertraline Hcl | Sertraline Hcl | 326 | 83 |
| Clopidogrel | Clopidogrel Bisulfate | 324 | 82 |
| Metoprolol Tartrate | Metoprolol Tartrate | 312 | 114 |
| Losartan Potassium | Losartan Potassium | 282 | 78 |
| Gabapentin | Gabapentin | 280 | 99 |
| Pantoprazole Sodium | Pantoprazole Sodium | 275 | 103 |
| Metformin Hcl | Metformin Hcl | 253 | 76 |
| Escitalopram Oxalate | Escitalopram Oxalate | 245 | 63 |
| Carvedilol | Carvedilol | 244 | 73 |
| Ondansetron Hcl | Ondansetron Hcl | 223 | 54 |
| Xarelto | Rivaroxaban | 219 | 39 |
| Mirtazapine | Mirtazapine | 208 | 59 |
| Duloxetine Hcl | Duloxetine Hcl | 206 | 65 |
| Donepezil Hcl | Donepezil Hcl | 204 | 49 |
| Allopurinol | Allopurinol | 181 | 45 |
| Quetiapine Fumarate | Quetiapine Fumarate | 181 | 42 |
| Bumetanide | Bumetanide | 171 | 60 |
| Jardiance | Empagliflozin | 157 | 34 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 155 | 37 |
| Omeprazole | Omeprazole | 154 | 78 |
| Spironolactone | Spironolactone | 149 | 52 |
| Divalproex Sodium | Divalproex Sodium | 143 | 33 |
| Buspirone Hcl | Buspirone Hcl | 141 | 44 |
| Citalopram Hbr | Citalopram Hydrobromide | 137 | 46 |
| Memantine Hcl | Memantine Hcl | 133 | 33 |
| Levetiracetam | Levetiracetam | 130 | 39 |
| Hydrochlorothiazide | Hydrochlorothiazide | 126 | 32 |
| Baclofen | Baclofen | 119 | 34 |
| Famotidine | Famotidine | 115 | 32 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 114 | 25 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 112 | 45 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 111 | 28 |
| Hydralazine Hcl | Hydralazine Hcl | 103 | 28 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 98 | 41 |
| Tizanidine Hcl | Tizanidine Hcl | 98 | 24 |
| Finasteride | Finasteride | 90 | 28 |
| Midodrine Hcl | Midodrine Hcl | 90 | 43 |
| Fluoxetine Hcl | Fluoxetine Hcl | 89 | 27 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 89 | 33 |
| Diclofenac Sodium | Diclofenac Sodium | 88 | 29 |
| Montelukast Sodium | Montelukast Sodium | 87 | 36 |
| Ropinirole Hcl | Ropinirole Hcl | 86 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 83 | 53 |
| Amiodarone Hcl | Amiodarone Hcl | 83 | 24 |
| Latanoprost | Latanoprost | 81 | 24 |
| Prednisone | Prednisone | 81 | 45 |
| Warfarin Sodium | Warfarin Sodium | 81 | 15 |
| Gemtesa | Vibegron | 75 | suppressed |
| Olanzapine | Olanzapine | 74 | 20 |
| Pravastatin Sodium | Pravastatin Sodium | 74 | 18 |
| Alendronate Sodium | Alendronate Sodium | 71 | 23 |
| Lamotrigine | Lamotrigine | 70 | 14 |
| Risperidone | Risperidone | 69 | 13 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 68 | 12 |
| Fluconazole | Fluconazole | 66 | 29 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 66 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 64 | 33 |
| Atenolol | Atenolol | 63 | 14 |
| Simvastatin | Simvastatin | 63 | 25 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 61 | 24 |
| Divalproex Sodium Er | Divalproex Sodium | 59 | suppressed |
| Methocarbamol | Methocarbamol | 59 | 23 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 57 | 27 |
| Cephalexin | Cephalexin | 55 | 33 |
| Digoxin | Digoxin | 55 | 15 |
| Meclizine Hcl | Meclizine Hcl | 53 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 51 | 22 |
| Entresto | Sacubitril/Valsartan | 49 | 15 |
| Vraylar | Cariprazine Hcl | 49 | suppressed |
| Insulin Lispro | Insulin Lispro | 48 | 21 |
| Amitriptyline Hcl | Amitriptyline Hcl | 45 | 12 |
| Farxiga | Dapagliflozin Propanediol | 45 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 45 | 20 |
| Januvia | Sitagliptin Phosphate | 44 | suppressed |
| Bupropion Xl | Bupropion Hcl | 43 | 16 |
| Torsemide | Torsemide | 43 | 13 |
| Clonidine Hcl | Clonidine Hcl | 40 | 16 |
| Doxycycline Hyclate | Doxycycline Hyclate | 40 | 23 |
| Humalog Kwikpen U-100 | Insulin Lispro | 40 | 12 |
| Myrbetriq | Mirabegron | 40 | 15 |
| Trulicity | Dulaglutide | 39 | 11 |
| Meloxicam | Meloxicam | 38 | 19 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 37 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 37 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 37 | 19 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 35 | suppressed |
| Tradjenta | Linagliptin | 35 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 34 | 16 |
| Lovastatin | Lovastatin | 34 | 11 |
| Topiramate | Topiramate | 34 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 33 | 15 |
| Clindamycin Hcl | Clindamycin Hcl | 33 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 33 | 11 |
| Ammonium Lactate | Ammonium Lactate | 32 | suppressed |
| Dofetilide | Dofetilide | 32 | suppressed |
| Nystatin | Nystatin | 32 | 20 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 31 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 30 | suppressed |
| Brilinta | Ticagrelor | 30 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 30 | 17 |
| Venlafaxine Hcl | Venlafaxine Hcl | 30 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 30 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 29 | 19 |
| Aripiprazole | Aripiprazole | 29 | 14 |
| Budesonide | Budesonide | 29 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 29 | 25 |
| Metoclopramide Hcl | Metoclopramide Hcl | 29 | 12 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 28 | 11 |
| Labetalol Hcl | Labetalol Hcl | 28 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 28 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 27 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 27 | 12 |
| Humalog | Insulin Lispro | 26 | suppressed |
| Lactulose | Lactulose | 26 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 26 | 14 |
| Sodium Chloride | 0.9 % Sodium Chloride | 26 | 17 |
| Sucralfate | Sucralfate | 26 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 25 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 25 | suppressed |
| Ibuprofen | Ibuprofen | 25 | 11 |
| Lidocaine | Lidocaine | 25 | suppressed |
| Primidone | Primidone | 25 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 25 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 25 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 24 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 24 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 24 | 13 |
| Roflumilast | Roflumilast | 24 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 24 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 23 | 18 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 23 | 18 |
| Fenofibrate | Fenofibrate Nanocrystallized | 22 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 22 | suppressed |
| Azithromycin | Azithromycin | 21 | 13 |
| Ketoconazole | Ketoconazole | 21 | suppressed |
| Levofloxacin | Levofloxacin | 21 | suppressed |
| Timolol Maleate | Timolol Maleate | 21 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 20 | suppressed |
| Enulose | Lactulose | 20 | suppressed |
| Nifedipine Er | Nifedipine | 20 | suppressed |
| Calcitriol | Calcitriol | 19 | suppressed |
| Carbamazepine | Carbamazepine | 19 | suppressed |
| Glimepiride | Glimepiride | 19 | suppressed |
| Glipizide | Glipizide | 19 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 19 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 19 | suppressed |
| Valsartan | Valsartan | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 18 | 11 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 18 | suppressed |
| Nitroglycerin | Nitroglycerin | 18 | 16 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 17 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Methotrexate | Methotrexate Sodium | 17 | 11 |
| Oxcarbazepine | Oxcarbazepine | 17 | suppressed |
| Cefdinir | Cefdinir | 16 | suppressed |
| Glipizide Er | Glipizide | 16 | suppressed |
| Linzess | Linaclotide | 16 | suppressed |
| Mirabegron Er | Mirabegron | 16 | 13 |
| Ondansetron Odt | Ondansetron | 16 | 14 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 16 | suppressed |
| Amantadine | Amantadine Hcl | 15 | suppressed |
| Calcium Acetate | Calcium Acetate | 15 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 15 | suppressed |
| Cholestyramine Light | Cholestyramine | 15 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 15 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 15 | suppressed |
| Anastrozole | Anastrozole | 14 | suppressed |
| Caplyta | Lumateperone Tosylate | 14 | suppressed |
| Ezetimibe | Ezetimibe | 14 | suppressed |
| Glatopa | Glatiramer Acetate | 14 | suppressed |
| Gvoke Hypopen 1-Pack | Glucagon | 14 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 14 | suppressed |
| Ranolazine Er | Ranolazine | 14 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 14 | suppressed |
| Amoxicillin | Amoxicillin | 13 | 11 |
| Celecoxib | Celecoxib | 13 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 13 | suppressed |
| Lyumjev | Insulin Lispro-Aabc | 13 | suppressed |
| Naproxen | Naproxen | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Novolog | Insulin Aspart | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 12 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 11 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 11 | suppressed |
| Ertapenem | Ertapenem Sodium | 11 | suppressed |
| Erythromycin | Erythromycin Base | 11 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 11 | suppressed |
| Fluvoxamine Maleate Er | Fluvoxamine Maleate | 11 | suppressed |
| Haloperidol | Haloperidol | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 11 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Riluzole | Riluzole | 11 | suppressed |
| Rivastigmine | Rivastigmine | 11 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $65.62 · 3 records | Teva Pharmaceuticals USA, Inc. | AUSTEDO XR, INGREZZA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error